chr11-1226857-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002458.3(MUC5B):​c.442G>A​(p.Val148Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00978 in 1,607,016 control chromosomes in the GnomAD database, including 99 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 6 hom., cov: 34)
Exomes 𝑓: 0.0099 ( 93 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.180

Publications

11 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0045601726).
BP6
Variant 11-1226857-G-A is Benign according to our data. Variant chr11-1226857-G-A is described in ClinVar as [Benign]. Clinvar id is 163993.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00993 (14444/1454958) while in subpopulation MID AF = 0.0248 (143/5766). AF 95% confidence interval is 0.0215. There are 93 homozygotes in GnomAdExome4. There are 7373 alleles in the male GnomAdExome4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.442G>A p.Val148Ile missense_variant Exon 4 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.442G>A p.Val148Ile missense_variant Exon 4 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84
MUC5BENST00000525715.5 linkn.500G>A non_coding_transcript_exon_variant Exon 4 of 26 1

Frequencies

GnomAD3 genomes
AF:
0.00838
AC:
1274
AN:
151940
Hom.:
6
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00713
Gnomad ASJ
AF:
0.00577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00643
Gnomad FIN
AF:
0.0166
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0120
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.00924
AC:
2206
AN:
238700
AF XY:
0.00943
show subpopulations
Gnomad AFR exome
AF:
0.00224
Gnomad AMR exome
AF:
0.00624
Gnomad ASJ exome
AF:
0.00703
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0162
Gnomad NFE exome
AF:
0.0120
Gnomad OTH exome
AF:
0.00986
GnomAD4 exome
AF:
0.00993
AC:
14444
AN:
1454958
Hom.:
93
Cov.:
35
AF XY:
0.0102
AC XY:
7373
AN XY:
724028
show subpopulations
African (AFR)
AF:
0.00197
AC:
66
AN:
33466
American (AMR)
AF:
0.00602
AC:
269
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.00793
AC:
207
AN:
26106
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39684
South Asian (SAS)
AF:
0.00752
AC:
648
AN:
86204
European-Finnish (FIN)
AF:
0.0168
AC:
794
AN:
47180
Middle Eastern (MID)
AF:
0.0248
AC:
143
AN:
5766
European-Non Finnish (NFE)
AF:
0.0106
AC:
11803
AN:
1111600
Other (OTH)
AF:
0.00849
AC:
512
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
908
1816
2723
3631
4539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00838
AC:
1275
AN:
152058
Hom.:
6
Cov.:
34
AF XY:
0.00844
AC XY:
627
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41498
American (AMR)
AF:
0.00712
AC:
109
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00577
AC:
20
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5098
South Asian (SAS)
AF:
0.00665
AC:
32
AN:
4814
European-Finnish (FIN)
AF:
0.0166
AC:
176
AN:
10600
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.0120
AC:
814
AN:
67960
Other (OTH)
AF:
0.0152
AC:
32
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00986
Hom.:
4
Bravo
AF:
0.00687
TwinsUK
AF:
0.00755
AC:
28
ALSPAC
AF:
0.0106
AC:
41
ESP6500AA
AF:
0.00173
AC:
7
ESP6500EA
AF:
0.00997
AC:
83
ExAC
AF:
0.00965
AC:
1163
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.00998
EpiControl
AF:
0.0113

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MUC5B: BP4, BS1, BS2 -

not specified Benign:1
May 11, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Val148Ile in exon 4 of MUC5B: This variant is not expected to have clinical si gnificance because it has been identified in 1.2% (795/61246) of European chromo somes, including 6 homozygotes, by the Exome Aggregation Consortium (ExAC, http: //exac.broadinstitute.org; dbSNP rs56293203). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
3.8
DANN
Benign
0.58
DEOGEN2
Benign
0.021
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.53
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-0.77
T
MutationAssessor
Benign
1.1
L
PhyloP100
-0.18
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.73
N
REVEL
Benign
0.16
Sift
Benign
0.16
T
Polyphen
0.0020
B
Vest4
0.12
MVP
0.12
ClinPred
0.0024
T
GERP RS
-3.7
Varity_R
0.046
gMVP
0.58
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56293203; hg19: chr11-1248087; API